China To Redo SFDA To Merge Authorities From 13 Government Agencies
This article was originally published in PharmAsia News
China is about to expand the duties of its State FDA to include food and drug responsibilities now spread among more than a dozen government ministries and agencies, according to sources.
You may also be interested in...
Phase III data earns a breakthrough therapy designation for Resverlogix’ apabetalone; previous companies to follow that strategy swiftly advance to NDA submission, as seen with Novartis’ capmatinib and Seattle Genetics’ tucatinib.
Pink Sheet analysis finds that evidence from early-stage trials supports most BTD requests, but about three in 10 designations are granted on the basis of pivotal-stage data.
Four House hearings show how far away even many Democrats are from supporting a single payer system in the US.